Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.66%
#2 Venom Venom +22.52%
#3 aelf aelf +12.97%
#4 TRIA TRIA +8.74%
#5 Decred Decred +7.98%
#6 Status Status +7.87%
#7 DexNet DexNet +7.56%
#8 MarsCoin MarsCoin +7.36%
#9 Pons Pons +7.15%
#10 Wibx Wibx +5.97%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cell MedX Corp. Cell MedX Corp.

Cell MedX Corp.

CMXC
Rang in Aktien #30406
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing,... Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
Aktienkurs
$0.41
Zuletzt synchronisiert: 2024-12-24
Marktkapitalisierung
$16.96M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Cell MedX Corp. (CMXC)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Cell MedX Corp. (CMXC)
Dividendenrendite (TTM) von Cell MedX Corp. (Aktienkürzel: CMXC) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Cell MedX Corp. (CMXC) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US